Cargando…

Impact of advanced Parkinson’s disease on caregivers: an international real-world study

BACKGROUND: Caring for a partner or family member with Parkinson’s disease (PD) negatively affects the caregiver’s own physical and emotional well-being, especially those caring for people with advanced PD (APD). This study was designed to examine the impact of APD on caregiver perceived burden, qua...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martinez-Martin, Pablo, Skorvanek, Matej, Henriksen, Tove, Lindvall, Susanna, Domingos, Josefa, Alobaidi, Ali, Kandukuri, Prasanna L., Chaudhari, Vivek S., Patel, Apeksha B., Parra, Juan Carlos, Pike, James, Antonini, Angelo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Original Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835744/ https://www.ncbi.nlm.nih.gov/pubmed/36633671 http://dx.doi.org/10.1007/s00415-022-11546-5

Ejemplares similares

Psychometric Properties of Clinical Indicators for Identification and Management of Advanced Parkinson’s Disease: Real-World Evidence From G7 Countries
por: Antonini, Angelo, et al.
Publicado: (2022)

Does the 5–2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5–2-1-positive patients in 7 countries
por: Malaty, Irene A., et al.
Publicado: (2022)

Infusion Therapies in the Treatment of Parkinson’s Disease
por: van Laar, Teus, et al.
Publicado: (2023)

Comparative Effectiveness of Device-Aided Therapies on Quality of Life and Off-Time in Advanced Parkinson’s Disease: A Systematic Review and Bayesian Network Meta-analysis
por: Antonini, Angelo, et al.
Publicado: (2022)

Comparative Effectiveness of Carbidopa–Levodopa Enteral Suspension and Deep Brain Stimulation on Parkinson’s Disease-Related Pill Burden Reduction in Advanced Parkinson’s Disease: A Retrospective Real-World Cohort Study
por: Soileau, Michael J., et al.
Publicado: (2022)

Update on the Management of Parkinson's Disease for General Neurologists
por: Pirtošek, Zvezdan, et al.
Publicado: (2020)

Accuracy of Rating Scales and Clinical Measures for Screening of Rapid Eye Movement Sleep Behavior Disorder and for Predicting Conversion to Parkinson’s Disease and Other Synucleinopathies
por: Skorvanek, Matej, et al.
Publicado: (2018)

Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson’s disease
por: Odin, Per, et al.
Publicado: (2018)

Patterns of Daily Motor-Symptom Control with Carbidopa/Levodopa Enteral Suspension Versus Oral Carbidopa/Levodopa Therapy in Advanced Parkinson’s Disease: Clinical Trial Post Hoc Analyses
por: Pahwa, Rajesh, et al.
Publicado: (2022)

The Cost Effectiveness of Levodopa-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson’s Disease in England
por: Chaudhuri, K. Ray, et al.
Publicado: (2022)

Long-term results of carbidopa/levodopa enteral suspension across the day in advanced Parkinson’s disease: Post-hoc analyses from a large 54-week trial
por: Pahwa, Rajesh, et al.
Publicado: (2022)

Continuous Subcutaneous Apomorphine Infusion in Parkinson’s Disease: A Single-Center, Long-Term Follow-Up Study of the Causes for Discontinuation
por: Henriksen, Tove, et al.
Publicado: (2021)

Effect of Pillbox Organizers with Alarms on Adherence to Pharmacotherapy in Parkinson Disease Patients Taking Three and More Daily Doses of Dopaminergic Medications
por: Straka, Igor, et al.
Publicado: (2022)

Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s Disease
por: Antonini, Angelo
Publicado: (2009)

The Parkinson’s Real-World Impact Assessment (PRISM) Study: A European Survey of the Burden of Parkinson’s Disease in Patients and their Carers
por: Tolosa, Eduardo, et al.
Publicado: (2021)

The Impact of Agitation in Dementia on Caregivers: A Real-World Survey
por: Schein, Jeff, et al.
Publicado: (2022)

Progressive choreodystonia in X‐linked hyper‐IgM immunodeficiency: a rare but recurrent presentation
por: Škorvánek, Matej, et al.
Publicado: (2022)

The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on ‘Off’-time in Patients with Advanced Parkinson’s Disease: A Systematic Review
por: Antonini, Angelo, et al.
Publicado: (2021)

Close relationships in Parkinson´s disease patients with device‐aided therapy
por: Scharfenort, Monica, et al.
Publicado: (2021)

Cognitive decline in Parkinson’s disease: the complex picture
por: Biundo, Roberta, et al.
Publicado: (2016)

Professionals’ Self-Reported Difficulties towards Integrating Dual Task Training in Care for People with Parkinson’s Disease
por: Domingos, Josefa, et al.
Publicado: (2022)

The Role of Dopamine Replacement on the Behavioural Phenotype of Parkinson’s Disease
por: Alobaidi, Hajar, et al.
Publicado: (2013)

Adherence to Pharmacotherapy in Patients With Parkinson's Disease Taking Three and More Daily Doses of Medication
por: Straka, Igor, et al.
Publicado: (2019)

Caregiver burden and its related factors in advanced Parkinson’s disease: data from the PREDICT study
por: Tessitore, Alessandro, et al.
Publicado: (2018)

Patient and caregiver outcomes with levodopa-carbidopa intestinal gel in advanced Parkinson’s disease
por: Valldeoriola, Francesc, et al.
Publicado: (2021)

Impact of the COVID-19 outbreak on neurological consultation in an emergency department
por: Maretta, Milan, et al.
Publicado: (2022)

Editorial: Impulse Control Disorders, Impulsivity and Related Behaviors in Parkinson's Disease
por: Rodríguez-Violante, Mayela, et al.
Publicado: (2019)

Once-daily pramipexole for the treatment of early and advanced idiopathic Parkinson’s disease: implications for patients
por: Antonini, Angelo, et al.
Publicado: (2011)

An Online Dual-Task Cognitive and Motor Exercise Program for Individuals With Parkinson Disease (PD3 Move Program): Acceptability Study
por: Domingos, Josefa, et al.
Publicado: (2022)

Clinical application of stem cell therapy in Parkinson's disease
por: Politis, Marios, et al.
Publicado: (2012)

Community Exercise: A New Tool for Personalized Parkinson’s Care or Just an Addition to Formal Care?
por: Domingos, Josefa, et al.
Publicado: (2022)

Current and novel infusion therapies for patients with Parkinson's disease
por: Antonini, Angelo, et al.
Publicado: (2023)

Correction to: Caregiver burden and its related factors in advanced Parkinson’s disease: data from the PREDICT study
por: Tessitore, Alessandro, et al.
Publicado: (2020)

Practical use of apomorphine infusion in Parkinson’s disease: lessons from the TOLEDO study and clinical experience
por: Henriksen, Tove, et al.
Publicado: (2023)

Prevalence of Extrapyramidal Symptoms in In-Patients With Severe Mental Illnesses: Focus on Parkinsonism
por: Roiter, Beatrice, et al.
Publicado: (2020)

Replacing Dopamine Neurons in Parkinson’s Disease: How did it happen?
por: Björklund, Anders, et al.
Publicado: (2017)

Cognitive Impairment in Fall-Related Studies in Parkinson’s Disease
por: Domingos, Josefa M., et al.
Publicado: (2015)

Smell deficits in COVID-19 and possible links with Parkinson's disease
por: Emmi, Aron, et al.
Publicado: (2022)

The End Is the Beginning: Parkinson’s Disease in the Light of Brain Imaging
por: Bellucci, Arianna, et al.
Publicado: (2017)

Beyond the Dopaminergic System: Lessons Learned from levodopa Resistant Symptoms in Parkinson's Disease
por: Antonini, Angelo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_30bkofuikeip1d4kpqkko3lfk0